Suffolk Police Department mourns loss of K9 Scout
SUFFOLK, Va.(WAVY)– The Suffolk Police Department announced Tuesday afternoon the death of K9 Scout.
Scout was a four-year-old Bloodhound who was trained and certified as a working dog. He was taken to a local veterinarian hospital for a medical emergency early Tuesday morning where he later died.
He joined the police department in May 2021 as the first Bloodhound for the department in almost 50 years. Scout, along with his dedicated handler, Master Police Officer S. Powell, completed training and were certified through the Virginia Work Dog Association for Trailing. In 2023, they both received an Award of Merit from the Virginia Police Work Dog Association for multiple finds.
During his time in the department, Scout received two Departmental Commendations and three Departmental Noteworthy Performance Awards.
'The Suffolk Police Department extend our condolences to K9 Scout's handler MPO Powell, members of the Suffolk Police Department's Canine Unit, and the community as a whole. K9 Scout was a dedicated member of our team that served the citizens of Suffolk well for several years.' says Suffolk Police Chief J. Buie.
Chief J. Buie also thanks the staff at Tidewater Animal Clinic as well as The Cove for their dedication and tireless efforts regarding K9 Scout.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
Suffolk Police Department mourns loss of K9 Scout
SUFFOLK, Va.(WAVY)– The Suffolk Police Department announced Tuesday afternoon the death of K9 Scout. Scout was a four-year-old Bloodhound who was trained and certified as a working dog. He was taken to a local veterinarian hospital for a medical emergency early Tuesday morning where he later died. He joined the police department in May 2021 as the first Bloodhound for the department in almost 50 years. Scout, along with his dedicated handler, Master Police Officer S. Powell, completed training and were certified through the Virginia Work Dog Association for Trailing. In 2023, they both received an Award of Merit from the Virginia Police Work Dog Association for multiple finds. During his time in the department, Scout received two Departmental Commendations and three Departmental Noteworthy Performance Awards. 'The Suffolk Police Department extend our condolences to K9 Scout's handler MPO Powell, members of the Suffolk Police Department's Canine Unit, and the community as a whole. K9 Scout was a dedicated member of our team that served the citizens of Suffolk well for several years.' says Suffolk Police Chief J. Buie. Chief J. Buie also thanks the staff at Tidewater Animal Clinic as well as The Cove for their dedication and tireless efforts regarding K9 Scout. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Boston Globe
23-05-2025
- Boston Globe
Today in History: May 23, outlaws Bonnie and Clyde killed in police ambush
In 1934, bank robbers Bonnie Parker and Clyde Barrow were shot to death during a police ambush in Bienville Parish, La. In 1945, Nazi official Heinrich Himmler killed himself while in British custody in Lüneburg, Germany. Advertisement In 1984, Surgeon General C. Everett Koop issued a report saying there was 'very solid' evidence linking cigarette smoke to lung disease in non-smokers. In 2013, the Boy Scouts of America announced it would remove membership restrictions based on sexual orientation, while maintaining a ban on openly gay Scout leaders. (The ban on gay Scout leaders and organization employees was lifted two years later.) In 2015, supporters of marriage equality in Ireland celebrated as referendum results showed a constitutional amendment in favor of recognizing same-sex marriage, passing by a nearly 2-to-1 margin. In 2018, NFL owners approved a new policy allowing players to protest during the national anthem by staying in the locker room, but forbidding players from sitting or taking a knee if they are on the field. Advertisement In 2021, a cable car taking visitors to a mountaintop view of northern Italy's Lake Maggiore plummeted to the ground when a cable snapped, killing 14 people.
Yahoo
22-05-2025
- Yahoo
Clinical Trials Matching Software Market Trends Analysis Report 2025-2030: Pharmaceutical and Biotech Firms Lead in Clinical Trials Software Utilization, Web and Cloud Solutions Propel Adoption
Clinical Trials Matching Software Market Dublin, May 22, 2025 (GLOBE NEWSWIRE) -- The "Clinical Trials Matching Software Market Size, Share & Trends Analysis Report by Deployment Mode (Web & Cloud-based, on-premise), End Use (Pharmaceutical & Biotechnology Companies, Medical Device Companies), Region, with Growth Forecasts, 2025-2030" report has been added to Clinical Trials Matching Software Market was valued at USD 187.09 Million in 2024, and is projected to reach USD 396.13 Million by 2030, rising at a CAGR of 13.45% The significant increase in the number of ongoing clinical trials is likely to drive the market. In addition, the growing adoption of the clinical trial matching software catering to the clinical trials, along with the increased demand for virtual trials and automation in the healthcare sector are some of the key factors contributing to the market growth. The matching software help in effective and fast patient matching with patient-centric approaches. In clinical trials, patient recruitment or matching can be time-consuming, and finding the right match can be a hurdle. Screening or locating prospective respondents who are qualified, considering all elements of the trials, verifying awareness, and getting informed consent to participate are the factors taken into consideration while recruiting patients. Enlisting the individuals in accordance with the qualifying requirements is crucial, hence the trial matching technology has been proved to be useful, especially in the COVID-19 software helps not only to find the right match but also saves the R&D-related costs, enabling smoother operations without human intervention. The software providers are introducing new innovative techniques to strengthen their market position. For instance, in February 2022, the CTMA expanded CT-SCOUT technology offering in Trials Matching Software Market Report Highlights Based on deployment mode, the web and cloud based segment dominated the market in terms of revenue in 2024 and it is expected to register the fastest CAGR during the forecast period. The cloud computing models operate with no maintenance or upkeep charges and customers only have to pay for the services that are used. On the other hand, on-premises deployment involves in-house infrastructure, in-house IT support, working capital, and higher integration costs. Hence, web and cloud based models are preferred Based on end use, pharmaceuticals and biotechnology companies captured the largest revenue share in 2024 owing to the higher adoption of software during ongoing clinical studies for cost-saving in the R&D activities Contract Research Organizations (CRO) segment is expected to register the fastest CAGR over the forecast period. CROs provide the professional assistance, expertise, and execution experience required for clinical trials quickly, without the need for the sponsor to engage such people full-time. CROs are preferred for outsourcing as their services are cost and time-effective In 2024, North America led the market in terms of revenue owing to the rising adoption of the clinical trial matching software by the pharma, biotech, and medical companies in the region Asia-Pacific is anticipated to register the fastest growth rate over the forecast period due to the availability of a large patient pool supporting easy recruitment of patients/candidates Why Should You Buy This Report? Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments. Competitive Landscape: Explore the market presence of key players. Future Trends: Discover the pivotal trends and drivers shaping the future of the market. Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions. Key Attributes: Report Attribute Details No. of Pages 120 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $187.09 Million Forecasted Market Value (USD) by 2030 $396.13 Million Compound Annual Growth Rate 13.4% Regions Covered Global Clinical Trials Matching Software Market Variables, Trends & Scope Market Driver Analysis Growing Complexity of Clinical Trials Increasing Demand for Precision Medicine & Personalized Trials Regulatory Push for Enhanced Patient Enrollment Efficiency Rising Investments in Digital Health & Clinical Research Technologies Expanding Clinical Trial Pipelines & Decentralized Trials Partnerships Between Pharma Companies & Tech Firms for Advanced Solutions Market Restraint Analysis High Implementation and Maintenance Costs Data Privacy and Security Concerns Market Opportunities Analysis Clinical Trials Matching Software Market Analysis Tools Industry Analysis - Porter's PESTEL Analysis Emerging Technologies Case Studies & Insights COVID-19 Impact Analysis Companies Featured IBM Antidote Technologies, Inc. Ofni Systems Clario Advarra ArisGlobal BSI Business Systems Integration AG Teckro Limited Evidation Health, Inc. HealthMatch Microsoft Inspirata, Inc. Mendel Health Inc. MatchTrial Curewiki Inteliquet (IQVIA) Tempus Labs For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Clinical Trials Matching Software Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
